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A series of copolymers of glycine and DL- 
lactic acid with various compositions was 
synthesized and their in nis'o and in vitro 
degradation behavior was studied. For the 
in vioo examination, discs of the copoly- 
mer films were subcutaneously implanted 
in rats. The in vitro studies were carried 
out in phosphate buffer at pH = 7.4 and 
37°C. The decrease in molecular weight, 
the loss of weight, and the tissue reactions 
of the different copolymers were deter- 
mined after 2, 5, and 10 weeks. Poly(DL- 
lactic acid) was used as reference material. 
The in ziiuo and in ziitro degradation behav- 
ior of the polymers was comparable. The 
decrease of molecular weight of the co- 
polymers and poly(D1-lactic acid) in time 
was similar. The weight loss for copolymers 
with a higher mole fraction of glycine 
units started earlier. The copolymer with 
the highest content of glycine units dis- 
appeared completely within 10 weeks both 
in ZI"I and in v i tro.  The poly(D1-lactic 
acid) implant lost only 25% weight over 
the same period. Tissue reactions against 
all materials started with an acute inflam- 
matory reaction caused by the trauma of 
implantation, followed by wound-healing 
processes, ending in a very mild foreign 
body reaction for the poly(D1-lactic acid) 
and a more excessive macrophage medi- 
ated foreign body reaction for the glycinei 
DL-lactic acid copolymers. The tissue 
reaction was more severe for polymers 
having a higher rate of degradation. 
INTRODUCTION 
The development of biodegradable polymers for use as suture materials, 
implants, and drug delivery devices has received much attention during the 
last two decades.'-3 Biodegradable polymers are preferably composed of 
residues normally present in the human body, e.g., lactid acid,"' glycolic 
acid,4,5,8,9 hydroxy butyric acid, lo or a-amino acids. 2~11~13 
The chemical and biological performance of many of these polymers has 
already been evaluated. Salthouse and Matlag~i '~, '~ have investigated the 
degradation and tissue reactions of polyglactin 910, a copolymer of L-lactid 
acid and glycolic acid. These authors showed that the in vivo degradation of 
this polymer was caused by bulk hydrolysis and that the presence of en- 
zymes did not influence the rate of degradation. The degradation products 
L-lactic acid and glycolic acid were actively metabolized by the cells sur- 
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rounding the implant. Williams,16 however, claimed that the degradation of 
similar polymers in vitvo was accelerated by the presence of enzymes. 
In general, tissue reactions which were observed after implantation of a 
biodegradable material such as polyglactin 910, are characterized by an ini- 
tial migration of polymorphonuclear and eosinophylic granulocytes toward 
the site of implantation. If the implant site is not infected, these cells disap- 
pear after approximately 3 days. If the material is not immunogenic, 
lymphocytes will not populate the implantation site. After 1 day macro- 
phages migrate toward the implant and try to envelop the foreign material. 
Macrophages and, in a later stage, foreign body giant cells will remain in 
the vicinity of the implanted material until it has completely degraded.10,1'817 
The severity of tissue reaction, and especially the role of the macrophages, 
is influenced by the biocompatibility of the polymer, the rate of degrada- 
tion, and mechanical stresses exerted by the implant. The local mechanical 
stresses are dependent on the sample shape.l7-I9 
Copolymers offer the possibility to obtain materials with a wide range in 
mechanical properties and rates of degradation. Although several copoly- 
mers of a-hydroxy acids and copolymers of a-amino acids have been prepared 
and extensively biologically evaluated the work on polydepsipeptides, co- 
polymers of a-hydroxy acids dnd a-amino acids has been rather limited. 
The synthesis and conformational properties of sequential polydepsipep- 
tides were studied by Goodman et a1.20,21 Kaetsu et al. l9 22 studied the in vivo 
degradation of melt pressed films of sequential polydepsipeptides such as 
poly(Ala-X-Glu(0Et)-Lac) (X = Gly, Ala and Leu). These films were ab- 
sorbed within several weeks of implantation (rats). The absorption rate was 
lower when the side chain of the amino acid X was larger.24 A systematic 
study on the degradation mechanism of polydepsipeptides has not yet been 
performed. 
We have prepared copolymers of glycine and DL-lactic acid with different 
 composition^.^^ Discs of these copolymers were subcutaneously implanted 
in rats and the tissue reaction and rate of degradation were studied as a 
function of time. Poly(DL-Lactic acid) (PDLA) was used as reference mate- 
rial. The results of the in vivo degradation were compared with those ob- 
tained in vitvo . 
MATERIALS AND METHODS 
Synthesis and characterization 
The copolymers used in this study were synthesized by ring-opening poly- 
merization of cyclo( glycine-DL-lactic acid) (monomer 1) and DL-dilactide 
(monomer 2) using stannous octoate [tin(II) bis(2-ethylhexanoate)] as ini- 
tiator (Fig. 1). Mole fractions of DL-dilactide in the feed of 0.60 and 0.80 
(sample codes 60 and 80) were applied. The copolymerization reaction was 
performed as described previously by Helder et aLZ3 The poly(DL-lactic 
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Figure 1. 
mole fraction of monomer 1. 
Synthesis of glycineiD1-lactic acid copolymers. x represents the 
acid) (sample code 100) was a gift from CCA biochem, Gorinchem, The 
Netherlands. 
The copolymers were characterized with respect to molar composition, 
apparent number average, and weight average molecular weights (Mn,app 
and Mw,app) and glass transition temperatures. 
Molar composition 
The molar composition of the copolymers was determined by ‘H-NMR 
spectroscopy. The spectra were recorded on a Nbolet 200 MHz NMR appa- 
ratus using CDC1, as a solvent and tetramethylsilane (TMS) as an internal 
reference. The composition was calculated from the methylene and methine 
proton integrations. The methylene proton signal at 4.0 ppm (Fig. 2) in the 
spectrum of the copolymer is characteristic of the glycine moiety from 
the (Gly-DL-Lac) unit (I). The methine proton signal at 5.1 ppm results 
from both monomeric units (1 and 2). 
8 7 6 5 4 3 2 1 0 PPm 
Figure 2. ‘H NMR spectrum (CDC13) of copolymer 60. 
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Molecular weights 
High performance gel permeation chomatography (GPC) was used to de- 
termine the molecular weight distributions, (Mn,app), Mw,app of the (co)poly- 
mer samples. The GPC unit consisted of a Waters model 6000 A pump and 
a Waters U6K injector, four Waters pStyragel (lo5, lo4, lo3, and 500 A in pore 
size) columns in series and a Waters R401 differential refractometer. Elution 
was performed at 25°C with a flow rate of 2.0 mL/min using tetrahydro- 
furan (THF) as eluent. The columns were calibrated with polystyrene stan- 
dards having a narrow molecular weight distribution. 
To obtain a better estimation of the real values of the initial molecular 
weights of the copolymers we have also determined Mn,ca,c values. The 
Mn,,,l, value of, e.g., copolymer 60 was obtained by multiplying the Mn,app 
value of copolymer 60 with the ratio Mn+/Mn,app* determined for a copolymer 
with the same composition but a different molecular weight. The M,,* value 
was measured by membrane osmometry and the Mn,apps value was mea- 
sured by GPC. 
It has to be realized that the Mn,app values measured in principle depend 
on the composition of the molecules. During degradation the molecular 
weight of the molecules is changing and also their chemical compositions 
may change. Therefore the Mn,app data may only be applied to compare the 
in vitvo and in vivo degradation of the same polymer sample. 
Glass transition temperatures 
Glass transition temperatures (T,) were measured with differential scan- 
ning calorimetry (DSC) using a DuPont 990 thermal analyzer and cell base. 
Prior to the measurements the samples (3-4 mg) were preheated at 130- 
150°C for 15 min and then cooled to room temperature. A heating rate of 
10"C/min and a sensitivity of 0.2 mcal/s were used. The T,  values were 
taken as the intersection of the extrapolation of the baseline with the ex- 
trapolation of the inflexion. 
Preparation of polymer discs 
Films were made by casting solutions of the (co)polymers in THF 
(15% w/v) onto glass surfaces (petri dishes), which were previously treated 
with a 30% v/v solution of dichlorodimethylsilane in toluene. The solvent 
was slowly removed by evaporation in air at room temperature for at least 
3 days, and subsequently at 40°C for 2 days at reduced pressure. The films 
were then immersed in demineralized water for 2 h to exchange residual 
solvent. After removal from the water the films were dried over P205 in 
vucuo for 18 h. The white films were cut into 8-mm-diameter discs which 
were dried under vacuum at 40°C for 18 h. The 'H NMR spectra of the (co)- 
polymers showed that traces of THF were present (Fig. 2). In order to re- 
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move the remaining THF the discs were immersed in 0.04 M phosphate 
buffer (pH = 7.2) at 4°C for 24 h. The buffer was exchanged every 4 h. After 
drying for 16 h over P205 in uucuo the 'H NMR spectra (CDCI,) of the (co)- 
polymers showed no THF present. 
Characterization of the discs 
The initial weight of the discs was 34.7 * 0.8 mg for copolymer 60, 
34.4 * 0.9 mg for copolymer 80 and 20.4 t 3 mg for polymer 100. The discs 
have an average thickness of 1.0 ? 0.1 mm. The discs were also examined 
by scanning electron microscopy (SEM) with a JEOL JSM 35 CF scanning 
electron microscope. The samples were coated with a charge conducting layer 
of gold using a Balzer sputter unit. Contact angles of water and a-bromo- 
naphthalene were determined by the sessile drop method as described by 
Busscher et al." 
In vitro degradation 
The in vitro degradation studies were performed at 37°C in 0.1 M 
Na,HP04/KH2P0, buffer pH = 7.4 containing 0.03 w/v % NaN,. The 
degradation was followed by determining the apparent molecular weight 
and weight at 0, 2, 5, and 10 weeks immersion in the buffer solution 
(n  = 3). 
In v i m  degradation 
After desinfection with 70% ethanol the discs were subcutaneously im- 
planted in female AO/BN rats 6 months of age and weighing approximately 
200 g. The wound was closed with one or two sutures (Dexon 4-0). Two 
discs were implanted on the back of each rat, one for determination of re- 
sidual weight and Mn,app, and one for studying the tissue reactions. For each 
copolymer and implantation time, one rat was used. After 2, 5, or 10 weeks 
the discs were removed. Discs for determination of residual weight and 
M,,app were carefully trimmed free of all surrounding tissue. Discs for deter- 
mination of tissue reactions were removed with excess surrounding tissue 
and immediately fixed in 2% glutaraldehyde in 0.1 M phosphate buffer 
(pH = 7.2) at 4°C for at least 12 h. 
Determination of weight 
After removal from the buffer solution or from the implant site the discs 
were dried in a desiccator in vacuo over P,O, for 24 h. The weight loss of 
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each disc was determined by comparing the dry weight of the degraded 
(co)polymer with the initial weight. 
Tissues reactions 
Specimens for studying tissue reactions were fixed in 2% glutaraldehyde 
and prepared for light microscopy by embedding in glycol methacrylate 
(GMA) as described in detail by Gerrits et a1.25 Samples were dehydrated in 
ethanol and subsequently pretreated for 2 h with 50% monomer solution in 
ethanol. The monomer solution consisted of 90 v/v % 2-hydroxyethyl 
methacrylate, 10 v/v % 2-butoxyethanol and 0.5 v/v % tribenzoylperoxide 
(initiator). Subsequently, the samples were treated with 100% monomer so- 
lution for 48 h. Afterward, the samples were polymerized for 40 min at 
room temperature by adding an accelerator solution (final concentration 
3 v/v %). The accelerator solution consisted of 6 v/v % N,N-dimethylaniline 
and 94 v/v % polyethylene glycol. After polymerization, 2-pm microtome 
sections were cut and stained with toluidene blue and alkaline fuchsine as 
described by Blaauw et a1.26 
RESULTS 
The molar compositions, initial molecular weights, and glass transition 
temperatures of the (co)polymers are listed in Table I. The calculated values 
of M, give a better estimation of the real molecular weight values. The data 
show that the initial molecular weight of copolymer 80 was somewhat 
higher than those of copolymer 60 and polymer 100 and that the molecular 
weights are in the same order of magnitude. 
The hydrophilicity of the (co)polymer films was determined using contact 
angle measurements. The contact angles of water and a-bromonaphthalene 
were 70" and 30" for copolymer 60, 75" and 25" for copolymer 80 and 80" 
and 20" for polymer 100, respectively. The surface free energies as deter- 
mined by the procedure of Busscher et al. are in the range of 54-63 erg/cm2. 
TABLE I 
Characterization of (Co)polymers Used for the Degradation Studies 
Sample Mole Fraction DL-Dilactide LW,,.~; M ,  calEb M,, appa T,' 
Code Units in the Copolymer ( X w 4 )  ( X  lo-*) (x  ("C) 
~~ 
60 0.64 f 0.03 0.6 1.5 1.8 69 
80 0.82 k 0.03 1.9 3.3 3.9 61 
100 1.00 2.4 2.0 5.2 54 
"Apparent molecular weights were measured by GPC. 
bCalculated M, values (see Materials and Methods). 
'Glass transition temperatures were measured by DSC. 
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Scanning electron micrographs show that the discs have a dense inner 
structure and pores of 5-10 pm near the surfaces (Fig. 3). The discs have a 
dense skin with an occasional cavity smaller than 1 pm (Fig. 4). 
Figures 4-6 show Mn,eqp and the residual weight of the discs as a function 
of time for both the in vzzm and in vitro studies. Copolymer 60 disappeared 
the fastest and in vitro a weight loss of 9770 within 10 weeks was observed 
(Fig. 5). Copolymer 80 lost 70% of its weight within 10 weeks (Fig. 6), 
whereas for polymer 100 a weight loss of 80% over the same period was ob- 
served (Fig. 7). The Mn,app values of the (co)polymers immediately decreased 
from the onset of the experiment. 
After 2 weeks the implanted (co)polymers showed a decrease in Mn,app of 
about 50%. The degradation behavior in vivo was similar to that in vitro . In 
vivo the discs of copolymer 60 were almost completely absorbed after 
10 weeks. Discs of copolymer 80 and polymer 100 lost only 30% of their 
original weight over that same period. The rate of weight loss in vitro was 
higher than that in vim. 
The morphological appearance of all discs had hardly changed after 
2 weeks implantation, both macroscopically and microscopically (Fig. 8). 
After 5 weeks, the thickness of the discs of copolymers 60 and 80 had in- 
creased three times. The diameters were slightly diminished. Tissue had 
entered the polymer matrix and the discs started to desintegrate (Fig. 9). 
After 10 weeks of implantation the discs of copolymer 60 had almost com- 
pletely disappeared (Figs. 10 and 11). Discs of copolymer 80 were spherical 
with a diameter of approximately 5 mm. The discs of polymer 100 also 
showed signs of degradation, but still had their original appearance. 
After 2 weeks (Fig. 8) macrophages had already penetrated the implants 
of copolymer 60. Approximately five layers of macrophages and an occa- 
sional giant cell surrounded the implant. On top of these layers approxi- 
mately 10 layers of fibroblasts encapsulate the implant. After 5 weeks a large 
number of macrophages and giant cells were still observed and the im- 
plants were partly degraded (Fig. 9). Extensive tissue infiltration into the 
discs was seen. Blood vessels grow toward and into the implant. After 
10 weeks, hardly any polymer material was left (Fig. 10). Macrophage and 
giant cell activity were still observed. Many polymer fragments were seen 
inside macrophages and giant cells (Fig. 11). Macrophages containing poly- 
mer debris were occasionally observed outside the original implant site in- 
dicating removal of debris-laden macrophages. 
Copolymer 80 (Fig. 12) showed a similar macrophage mediated foreign 
body reaction as copolymer 60. After 2 weeks hardly any tissue infiltration 
into the implant was present. Approximately eight layers of macrophages 
and five layers of fibroblasts were surrounding the implant. After 5 weeks 
some tissue infiltration with macrophages and giant cells was seen (Fig. 13). 
After 10 weeks, extensive tissue infiltration was observed with far fewer 
phagocytes as compared to copolymer 60. 
Polymer 100 hardly showed any visible degradation and a minor tissue 
reaction. Even after 10 weeks only a minor phagocytic activity was observed 
around implants of this polymer (Fig. 14). 
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Figure 8. Copolymer 60 after 2 weeks implantation. Approximately five 
layers of macrophages and a sheet of fibroblasts surrounded the implant. 
Blood vessels close to the implant can be observed. The bar represents 
64 pm. 
Figure 9. Copolymer 60 after 5 weeks implantation. Macrophages have in- 
filtrated in the desintegrating polymer matrix. Giant cells can be observed. 
The bar represents 100 pm. 
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Figure 10. 
ments remain. The bar represents 40 pm. 
Copolymer 60 after 10 weeks implantation. Only small frag- 
Figure 11. Copolymer 60 after 10 weeks implantation. Polymer debris is 
engulfed by single macrophages or by giant cells. The bar represents 
100 pm. 
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Figure 12. 
tion into the implant can be observed. The bar represents 100 pm. 
Copolymer 80 after 2 weeks implantation. Hardly any infiltra- 
Figure 13. Copolymer 80 after 5 weeks implantation. The number of 
macrophages and giant cells is far less than with copolymer 60. Only small 
infiltrations into the implant are observed. The bar represents 100 pm. 
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Figure 14. Polymer 100 after 10 weeks implantation. Only minor giant cell 
and macrophage activity is observed. The sheet of fibroblast tissue around 
the implant is thinner than around copolymers 60 and 80. The bar repre- 
sents 100 pm. 
DISCUSSION 
The glycineiDL-lactic acid copolymers were synthesized by a ring-opening 
polymerization reaction of monomers 1 and 2 (Fig. 1). Previous studies 
showed that DL-dilactide (monomer 2) was preferentially incorporated into 
the copolymer. The discs prepared from the (co)polymers were studied by 
scanning electron microscopy and contact angle measurements. The scan- 
ning pictures (Figs. 3 and 4) show that initially the discs have a dense inner 
structure, pores near the surface and a dense skin. Contact angle measure- 
ments demonstrated that the surface free energy of the polymers increased 
with increasing glycine content, which corresponds with the more hydro- 
phylic character of glycine residues as compared to lactic acid residues. 
In a recent paper by our groupz7 an extensive in vitro degradation study 
was described, using glycineiDL-lactic acid copolymers with mole fractions 
of 0.50, 0.60, 0.70, 0.75, 0.80, and 0.90 DL-dilactide units. From the de- 
crease of the molecular weight as a function of time it was concluded that 
the degradation mechanism can be described as bulk hydrolysis of the ester 
bonds, autocatalyzed by the generated carboxylic end groups.2',28 It was fur- 
ther observed'? that the rate of ester bond scission was comparable for the 
copolymers. From the weight loss profiles it was concluded that copolymers 
with a higher percentage of glycine units dissolved earlier, which could be 
ascribed to a higher solubility of the low-molecular-weight fragments rich in 
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glycine units. The in vifro results described in this paper correspond to the 
results mentioned above.*' 
The decrease of the apparent molecular weight as a function of time was 
comparable in uitro and in vivo for the same copolymer (also see the remarks 
given in the section Molecular weights). The data suggest that the degrada- 
tion mechanism in vim is the same as observed in nitro: bulk hydrolysis of 
ester bonds. This indicates that the enzymatic degradation, as was deter- 
mined in the in vitro degradation of poly(L4actic acid)," does not play an 
important role. 
The rate of decrease of both molecular weight and weight loss were 
somewhat higher in vitro than in vivo . This phenomenon was also observed 
by Pitt et al.29 for the degradation of poly(D1-lactic acid), poly(e-caprolac- 
tone) and their copolymers. This phenomenon can possibly be explained by 
the formation of a tissue capsule around the implant causing an accumula- 
tion of degradation products. Furthermore the protein-containing environ- 
ment may cause a lower solubility of the copolymers. 
The in vivo weight loss started earlier for copolymers with a higher 
glycine content, which corresponds to the in vitro observations. Biodegrada- 
tion of the glycine/DL-lactic acid copolymers can be described by two 
stages. First the molecular weight decreases as a result of the ester bond 
scission described. This is illustrated by the instantaneous decrease of MTv,app 
and M,,app as shown in Figures 4-6. As soon as the fragments are small 
enough to become soluble, weight loss is observed. The time at which 
weight loss and consequently dissolution of the low molecular weight frag- 
ments occurs depends on the percentage of glycine units in the copolymer, 
and the initial molecular weight of the (co)polymer. 
The tissue reactions observed reflect a general wound-healing reaction 
followed by a phase of phagocytosis and removal of the material fragments. 
Tissue reactions were much more pronounced when the copolymers con- 
tained more glycine units due to the fact that during the degradation pro- 
cess, these copolymers are more rapidly dissolved. These observations 
correspond with work of other authors on copolymers of a-amino 
When the degradation of poly(D1-lactic acid), as studied in this article is 
compared with poly(L-lactic acid)I7 it is also observed that the lower rate of 
degradation of poly(L-lactic acid) is accompanied with a less severe tissue 
reaction. Poly(glyco1ic acid), which degrades even faster than poly(D1-lactic 
acid) showed a very severe macrophage mediated tissue r e s p ~ n s e . ~ , ~ ~  Blood 
vessels were observed to grow in the direction of the implant, probably 
caused by the release of a macrophage angiogenic f a ~ t o r . ~ ~ , ~ ~  
The biodegradability and tissue reactions of random copoly(a-amino 
acids) of L-leucine, L-aspartic acid, and L-aspartic acid esters were investi- 
gated by Marck et a1.l' Nondegradable hydrophobic copolymers showed a 
good biocompatibility. More hydrophllic copolymers showed some degrada- 
tion within 12 weeks, but the implant sites were populated by lymphocytes 
and plasma cells indicating antigenicity. Hydrophilic copolymers caused a 
temporary chemical inflammation and had disappeared within 24 h. Appar- 
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ently the rate of degradation and biocompatibility do not coincide in con- 
trast to the polydepsipeptides described in this paper. 
The in vivo degradation of poly(D1-lactic acid) has recently been studied 
by Visscher et al.” The microspheres, which were intramuscularly injected 
in rat legs, only showed signs of macrophage infiltration from day 150 on. 
After 420 days poly(D1-lactic acid) fragments were still present. The tissue 
reaction observed was similar to our findings. Macrophages and giant cells 
were persisting around the implanted particles until they had completely 
degraded. The rate of degradation is considerably lower than that of poly- 
(DL-lactic acid) described in this article, although the molecular weights in 
both studies were comparable. This discrepancy may be explained by the 
use of different implantation sites. 
Application of these biodegradable glycine/DL-lactic acid copolymers can 
be expected in the field of drug release from a polymer matrix.” The degra- 
dation time, and thus the kinetics of release, can be influenced by the com- 
position of the copolymer. 
CONCLUSIONS 
The glycineiD1-lactic acid copolymers and poly(D1-lactic acid) show a 
comparable in vivo and in vitro degradation behavior. The degradation takes 
place via bulk hydrolysis of the ester bonds. Increasing the mole fraction of 
glycine units in the copolymer leads to a faster absorption of material, al- 
though the rate of hydrolysis is not affected by the changes in composition. 
The tissue reaction can be characterized as a macrophage mediated foreign 
body reaction. It is more severe for polymers having a higher degradation 
rate, i.e., for copolymers with a higher glycine content. 
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